3-Year-Old Boy Infected With Meningitis; No Data Shows Connection to UK Infection Cluster

The Centre for Health Protection is investigating a case of invasive meningococcal disease. The patient did not travel abroad during the incubation period, so it is classified as a local infection. Additionally, in response to recent clusters of invasive meningococcal disease in Kent, UK, the Centre has strengthened health screening at the airport for travelers showing suspected symptoms. Currently, there are no reported cases of imported invasive meningococcal disease among travelers arriving from the UK to Hong Kong.

The Centre states that the case involves a previously healthy 3-year-old boy who developed fever and vomiting starting on the 17th of this month. He was taken to the Accident & Emergency Department of Kwong Wah Hospital the next day and admitted for treatment. His condition is serious. Laboratory tests on his blood and cerebrospinal fluid samples confirmed positive results for meningococcal bacteria, with a clinical diagnosis of meningitis.

Initial investigations show that the patient did not travel abroad during the incubation period, and his household contacts have not shown symptoms so far. The Centre has provided prophylactic medication to close contacts and continues to investigate. Preliminary findings indicate that this is an isolated case, with no epidemiological link to previously confirmed cases in Hong Kong or recent infection clusters in the UK.

The Centre has been closely monitoring the meningococcal infection clusters in Kent, UK, over the past week. Director of Health, Dr. Chui Leung-kan, said that, according to the latest data, the number of cases in the UK cluster continues to rise, from 20 to 29, with two students having died. The cases mainly involve young people, including some students from the University of Kent or individuals who visited a nightclub called “Club Chemistry” in the area from March 5 to 7.

He added that, although no notifications have been received from UK health authorities regarding Hong Kong students involved in the cluster or close contacts, the Centre has prepared health information about invasive meningococcal disease. This information will be distributed later through the Hong Kong Economic and Trade Office in London to local Hong Kong students. Regarding entry measures, the Centre has strengthened health screening at the airport for travelers showing suspected symptoms to facilitate prompt referral for medical examination.

The Centre will also notify all doctors in Hong Kong to be vigilant for patients returning from affected areas who may have symptoms related to invasive meningococcal disease. The Centre will maintain close communication with UK health authorities and take appropriate follow-up actions based on risk assessments.